Adjusted odds ratios (AORs) and 95% confidence intervals (CI) of clinical statuses associated with genotypic frequencies of SERPINB5 in oral cancer patients (n = 741). The gene discussed is SERPINB5; the disease is lip and oral cavity carcinoma.